Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer

NCT03658772 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Microsatellite Stable Colorectal Cancer

Interventions

DRUG: grapiprant
DRUG: grapiprant and pembrolizumab

Sponsor

Arrys Therapeutics

Collaborators

[object Object]